The MET oncogene as a therapeutical target in cancer invasive growth
The MET proto-oncogene, encoding the tyrosine kinase receptor for Hepatocyte Growth Factor (HGF) regulates invasive growth, a genetic program that associates control of cell proliferation with invasion of the extracellular matrix and protection from apoptosis. Physiologically, invasive growth takes...
Saved in:
Main Authors: | Paolo eLuraghi (Author), Florian eSchelter (Author), Achim eKrüger (Author), Carla eBoccaccio (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ON THE PRO-METASTATIC STRESS RESPONSE TO CANCER THERAPIES: EVIDENCE FOR A POSITIVE CO-OPERATION BETWEEN TIMP-1, HIF-1α, AND miR-210
by: Haissi eCui, et al.
Published: (2012) -
The MET Oncogene: An Update on Targeting Strategies
by: Simona Gallo, et al.
Published: (2024) -
Differential impact of cysteine cathepsins on genetic mouse models of de novo carcinogenesis: cathepsin B as emerging therapeutic target
by: Thomas eReinheckel, et al.
Published: (2012) -
The MET Oncogene: Thirty Years of Insights into Molecular Mechanisms Driving Malignancy
by: Tiziana Crepaldi, et al.
Published: (2024) -
CXCR4 in breast cancer: oncogenic role and therapeutic targeting
by: Xu C, et al.
Published: (2015)